Emmanuel Caprais
Analyst · UBS
Thank you, Luca. From a top line perspective, ITT drove 7% organic growth in the first quarter. CCT delivered 23% organic growth, driven by continued industrial connector strength and recovery in aerospace. In MT, Friction was up 5% organically, driven by the continued momentum in the aftermarket. While OE was flat organically given the ongoing chip shortage, we still outperformed global auto production. And as Luca mentioned, the MT team has been relentless in driving price realization in partnership with our customers. For all of ITT, we estimate that the ongoing supply disruptions cost us approximately 600 basis points of top line growth in Q1, with the most pronounced impact in Industrial Process. Turning to operating income. Our teams drove productivity in the quarter of roughly 350 basis points of margin through a combination of shop floor and sourcing actions, which partially offset 760 basis points of cost inflation. From an earnings perspective, adjusted EPS declined roughly 8% versus 2021 despite the 7% increase in organic revenue. The difference is largely attributable to the significant cost inflation and impact of the war in Ukraine. And as a reminder, our first quarter results in 2021 were incredibly strong. We also absorbed unfavorable foreign currency, which was offset by the benefit of higher share repurchases and a lower effective tax rate. Finally, working capital requirements, continue to weigh on our free cash flow generation. We are purposefully investing in inventory to ensure we are able to guarantee delivery to our customers in this difficult time. We were also impacted by the timing of accounts receivable collections, given the large volume of sales in December. We expect that cash generation will improve beginning in Q2, notwithstanding the inventory requirements. Let’s now turn to Slide 8 to look further at the earnings performance. We’re driving strong volume growth and productivity through deployment of the MT operating model. Included in the $0.29 of operational performance improvement is roughly $0.22 of productivity. Pricing actions contributed to $0.20 to earnings, while volume contributed $0.07, with particular strength in CCT. These improvements, however, are still lagging the pace of material, labor and overhead inflation. As a result, we are enacting incremental pricing -- price increases through the portfolio to address the rising costs. In Q1, we suspended our operations in Russia given the war in Ukraine. We see direct impacts mainly in MT and IP as well as indirect impacts from OEM customers that sell and supply into this region. This cost us approximately $0.04 in the first quarter. In 2022, we expect this will result in a revenue decline of approximately $60 million to $85 million as compared to our original plan, which is factored into our current revenue outlook. Additionally, we are actively investing in M&A. These investments will help to fund future growth at ITT, and this quarter cost us roughly $0.02 of earnings. Finally, given the movement in foreign currency rates, we absorbed a $0.03 headwind in Q1 and expect this ongoing trend will drive at least a $0.09 headwind for the full year. Offsetting this first quarter headwind is the benefit of our share repurchases and a slightly lower tax rate. Let’s now turn to Slide 9 to review the segment results. Let me begin with Motion Technologies. Our Friction OE business maintained its outstanding on-time performance at over 99%, effectively managing the global supply chain disruptions and OEM production impacts created by the war in Ukraine. MT continues to be highly differentiated, thanks to its innovation and imperial quality and exceptional on-time delivery performance. By now, you probably are aware of the outstanding quality of our Friction business that produces less than 1 defect per million parts. Amazingly in Q1, the Friction team has been further improving their quality performance and reduce the defect rates by double digits versus 2021. I also want to highlight our KONI shock absorber business, which has improved its customer defect rate by an impressive 90% over the past 2 years, delivering an industry-leading quality performance. On profitability, MT’s segment margin declined 310 basis points. This was mainly due to higher-than-expected material inflation, partially offset by pricing actions and productivity benefits. We’re driving necessary pricing actions with our OEM customers. Finally, we completed the closure of our Lünen facility in Germany and transferred all production to Poland in Q1. For Industrial Process, organic revenue grew 2%, driven by short-cycle strength, partially offset by supply chain disruptions and labor constraints. IP shipments were impacted mainly in January by the rise of the COVID-19 Omicron variant at our U.S. and India sites. However, when looking at April, IP’s performance continues to improve, especially compared to what we experienced at the beginning of Q1. On the demand side, we are encouraged by the order strength in our short-cycle and project business. This was our fifth consecutive quarter of sequential order growth as short-cycle demand remains strong and project activity continues to strengthen. IP’s margin declined by 300 basis points. This was driven by unusually high cost for freight and materials as well as a slow start in January due to high COVID absenteeism. As a result, IP is undertaking substantial pricing actions to mitigate cost inflation, including a second larger price increase in March of this year. In Q1, I spent considerable time with our IP team in Seneca Falls and was impressed by the positive momentum we have generated on the shop floor over the past 5 months. We’re continuing to transform our operation by accelerating shop floor velocity and attacking waste in our processes. For example, we shortened the throughput of our small MT pump by over 50% by streamlining the product release process and reducing non-value-added activities in the assembly line. With these improvements achieved, we’re now shifting our focus to our midrange pump line. Lastly, on Connect and Control, we had our largest order quarter since Q1 2019 despite the fact that aerospace orders are still more than 30% below pre-COVID levels. Orders grew 28% organically versus prior year, driven by 40% growth in aerospace and defense. CCT’s margin expanded an impressive 550 basis points to 16.7%, driven by higher volume and shortfall productivity. Notably, CCT delivered 42% incremental margin in the face of these inflationary headwinds. This was without the benefit of significant pricing actions, which we will begin to realize in Q2. We will also expect -- we also expect that the product redesigns and range extension we launched, coupled with the process automation we will implement will drive further margin expansion in the near term. Let’s now turn to Slide 10, where we’ll provide an updated end market outlook. Our message here has not changed. Demand remains strong and we’re winning in the marketplace. However, the dynamics we noted around pricing, cost inflation and the war in Ukraine, will impact our results in the near term. In auto, inventories remain at historically low levels in North America and Europe, which should drive further demand, but deliveries continue to be impacted by the chip shortage. Profitability is being hit by inflation, and we’re now managing through further disruptions, namely COVID in China and the war in Ukraine. The war is also impacting our rail business. Demand remains generally strong in the industrial businesses. However, labor shortages and supply chain disruptions continue to weigh on our top line growth and margin expansion. Regarding aerospace, demand is improving, but we’re still well below sales levels from 2019. We expect this market to continue to steadily accelerate in the second half coinciding with a further increase in global travel and reduction in aero OEM inventory. All of this informs our guidance update on Slide 11. As you can see, we are reaffirming our guidance ranges for revenue, adjusted segment margin and adjusted EPS. We continue to expect organic sales growth of 9% to 11%. But given our first quarter performance, the strong demand we see in IP and CCT and the incremental pricing actions we are taking, we are trending towards the high end of our organic sales range for the full year. From a segment margin standpoint, for the full year, given the significant cost inflation headwinds, we’re trending towards the lower end of our current range. CCT will drive the strongest margin expansion, while MT margin will likely decline close to 200 basis points. Industrial Process margin will expand overcoming the ongoing supply chain disruptions, which will continue to constrain delivery in the first half. Additionally, the acquisition of Habonim will tamper margins in 2022, given M&A costs. As a result, we now expect IP to deliver between 15% and 16% margin for the year with a significant improvement in Q2 compared to Q1. Adjusted EPS will be impacted by the lost sales in Russia as well as the impact of cost inflation. We intend to offset this through a stronger-than-anticipated performance in CCT, lower share count and the addition of Habonim. The impact of these items suggest we may trend towards the lower end of our adjusted EPS guidance range. Our ability to drive better performance will depend in part on the cost of key raw materials, the pace at which we are able to realize benefits from price increases and the impact, if any, of prolonged lockdowns in China. Given our use of cash in Q1, free cash flow will likely be lower than anticipated in a new range of $250 million to $300 million, and free cash flow margin will approximately be 8% to 10%. Longer term, we still believe we can effectively improve our cash flow profile through reductions in working capital and earnings growth. In the event supply chain disruptions do not improve and raw material inflation gets worse, we’re planning to take further actions, including pricing and additional structural cost actions as we have demonstrated before. In terms of the cadence for the rest of the year, adjusted EPS for Q2 will be roughly flat sequentially to Q1. Organic sales growth in Q2 is expected to be in the mid-single-digit range, thanks to the growth in CCT and to a lesser degree in MT. We expect IP organic sales to increase in Q2 and then to improve sequentially in the third and fourth quarters. ITT’s segment margin in Q2 will likely be flat to Q1 at approximately 16%, with margin expansion in IP and CCT offset by an approximate a 200 basis point decline in MT margin sequentially given the material inflation headwind. This is obviously not the type of performance we like to see from MT. However, we expect MT’s margin will begin to improve sequentially in the third quarter as pricing actions are realized. With that, let me pass it back to Luca to wrap up.